Benutzer: Gast  Login
Mehr Felder
Einfache Suche
Titel:

Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper

Dokumenttyp:
Article
Autor(en):
Pfaar, O.; Bastl, K.; Berger, U.; Buters, J.; Calderon, M. A.; Clot, B.; Darsow, U.; Demoly, P.; Durham, S. R.; Gala'n, C.; Gehrig, R.; van Wijk, R. Gerth; Jacobsen, L.; Klimek, L.; Sofiev, M.; Thibaudon, M.; Bergmann, K. C.
Abstract:
Background: Clinical efficacy of pollen allergen immunotherapy (AIT) has been broadly documented in randomized controlled trials. The underlying clinical endpoints are analysed in seasonal time periods predefined based on the background pollen concentration. However, any validated or generally accepted definition from academia or regulatory authorities for this relevant pollen exposure intensity or period of time (season) is currently not available. Therefore, this Task Force initiative of the E...     »
Zeitschriftentitel:
Allergologie
Jahr:
2018
Band / Volume:
41
Heft / Issue:
9
Seitenangaben Beitrag:
386-399
Volltext / DOI:
doi:10.5414/ALX02053
Print-ISSN:
0344-5062
TUM Einrichtung:
Klinik und Poliklinik für Dermatologie und Allergologie; Molekulare Allergologie (Prof. Schmidt-Weber)
 BibTeX